SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001425738-17-000020
Filing Date
2017-12-19
Accepted
2017-12-19 17:16:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13g_redmile_a3_dec182017.htm SC 13G/A 68540
  Complete submission text file 0001425738-17-000020.txt   70127
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Subject) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87649 | Film No.: 171264834
SIC: 2836 Biological Products, (No Diagnostic Substances)